00742nas a2200253   4500000000100000008004100001100001600042700001500058700002300073700001300096700001300109700001400122700001000136700001200146700001500158700001600173700001600189700001700205700001700222245019800239300001200437490000700449022003200456       2020                            d1 aE. Heintjes1 aI. Bezemer1 aD. Prieto-Alhambra1 aE. Smits1 aH. Booth1 aD. Dedman1 aY. He1 aF. Hoti1 aM. Vehkala1 aS. de Vogel1 aN. Robinson1 aK. Appenteng1 aF. van Beest00aEvaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries  a423-4330 v12  a1179-1349 (Print) 1179-1349